🔎 Trials Near Me

Hjem › Glioblastom › Georgia

Glioblastom kliniske forsøg i Georgia

12 studier for Glioblastom søger deltagere på steder i Georgia.

Byer i Georgia

Officiel studietekst (engelsk)

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT05432804

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

  • Winship Cancer Institute at Emory University, Atlanta
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05902169

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Piedmont Oncology Research, Atlanta
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
RekruttererFase 1/2
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • Emory Winship Cancer Institute, Atlanta
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07195591

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  • Emory University Hospital/Winship Cancer Institute, Atlanta
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Emory University, Atlanta
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT05303519

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

  • Emory University Hospital/Winship Cancer Institute, Atlanta
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06319027

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

  • Emory University, Atlanta
RekruttererFase 1
Alder 2 til 21 · Alle køn · Opdateret 11. jun. 2026 · NCT04732065

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

  • Augusta University, Georgia Cancer Center, Augusta
RekruttererFase 1
Alder 3 til 25 · Alle køn · Opdateret 9. jan. 2026 · NCT05106296

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Atlanta
  • Massive Bio SYNERGY-AI site, Savannah
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

  • Emory University Hospital/Winship Cancer Institute, Atlanta
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2025 · NCT04590664

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.